NEWS and OPINIONS
Longeveron to Play Prominent Role at the World Stem Cell Summit in Miami
MIAMI, Jan. 22, 2018 /PRNewswire/ -- Longeveron LLC, regenerative medicine company, announced that it will help roll out the red carpet when investigators from around the globe converge on the company's hometown of Miami for the 2018 World Stem Cell Summit, January...
Aging Frailty with Influenza Vaccine Trial announced by Longeveron
America is facing one of the worst influenza seasons in recent history. The influenza virus is one of the top ten causes of death in elderly people. Longeveron is conducting a multi-center, randomized, placebo controlled trial using its Longeveron Mesenchymal Stem...
Longeveron Alzheimer’s Disease Trial
Allogeneic Human Mesenchymal Stem Cell Infusion Versus Placebo in Patients with Alzheimer’s Disease. Longeveron’s Phase I, prospective, randomized, placebo-controlled, double-blinded study is designed to test the safety and efficacy of Longeveron Mesenchymal Stem...
Longeveron Aging Frailty Phase 2b Trial
Longeveron is currently enrolling subjects in its Phase 2b multi-center clinical trial designed to test the safety and efficacy of Longeveron Mesenchymal Stem Cells (LMSCs) for the treatment of subjects with clinically diagnosed with Aging Frailty. This is the only...
Avalon GloboCare Corp. CEO David Jin, M.D., Ph.D. to Present and Chair the “China’s Impact on The World of Regenerative Medicine” Session at the 13th Annual World Stem Cell Summit
PRESS RELEASE Marketwired Jan. 21, 2018, 08:20 AM FREEHOLD, NJ (Marketwired - January 21, 2018) - Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies, announced today that President and Chief Executive Officer David Jin, M.D.,...
Mayo Clinic Center for Regenerative Medicine at the 2018 World Stem Cell Summit
The Mayo Clinic Center for Regenerative Medicine is a co-organizer of the 2018 World Stem Cell Summit. More than 1,000 attendees are expected at the 13th annual event Jan. 22-26 in Miami, Florida. Researchers and clinical experts from Mayo Clinic will participate in...
California’s Stem Cell Agency Invests in Phase 3 Clinical Trial to Help Kidney Transplant Patients
Posted: January 18, 2018 January 18, 2018 - Oakland, CA Over 650,000 Americans suffer from end-stage kidney disease - a life-threatening condition caused by the loss of kidney function. The best available treatment for these patients is a kidney transplant from a...
The Making of a Stem Cell Super-Ecosystem with Bernard Siegel
January 17, 2018 By Cade Hildreth (CEO) Leave a Comment I am honored to share this interview with Bernard Siegel, Executive Director of the Regenerative Medicine Foundation (RMF), a global network of stakeholders that fosters collaboration across the industry. Bernard...
Pioneers of Hope: Patient Advocate Doug Oliver’s Interview of Dr. Francis Collins, Director, National Institutes of Health (NIH)
The Regenerative Outcomes Foundation is proud to present the Pioneers of Hope, a series of our founder Doug Oliver’s personal interviews with leading influencers in the Regenerative Medicine movement. These articles are our way of sharing the hope that this field...
AgeX CEO Michael D. West to Present in Plenary Session at The World Stem Cell Summit on “Stem Cell Innovations That Will Change the World”
ALAMEDA, Calif.--(BUSINESS WIRE)--AgeX Therapeutics, Inc., a subsidiary of BioTime, Inc. (NYSE American: BTX), today announced that AgeX will present in a Plenary session, “Stem Cell Innovations That Will Change the World – Part 2,” at the World Stem Cell Summit...
NSU to present at World Stem Cell Summit
By Christina Mclaughlin - January 16, 2018 Researchers and faculty members from NSU’s College of Allopathic Medicine (M.D. College) will present their research in the fields of cancer immunotherapy and regenerative medicine at the 2018 World Stem Cell Summit from Jan....
Collaboration With Explosive Upside! World Stem Cell Summit- Phacilitate Cell & Gene Therapy World And Immuno-Oncology Frontiers World
Dear Colleagues, Twelve years ago my nonprofit organization, Genetics Policy Institute (now Regenerative Medicine Foundation) founded an annual conference that evolved into the World Stem Cell Summit. Over time, this event has brought together thousands of thought...